Navigation Links
Prostate Cancer Treatment Offers Results Without Side Effects
Date:5/28/2008

SARASOTA, Fla., May 28 /PRNewswire/ -- Mike Strong, a health minister for Hallelujah Acres, was only 52 when an annual physical revealed his Prostate Specific Antigen (PSA) was 31 (normal is 4 or under). Although he had no symptoms, a biopsy confirmed that he had cancer.

His doctor urged him to have a radical prostectomy to remove his prostate and surrounding tissue. He refused, but did agree to take the testosterone blocker Lupron for one year.

The Lupron made him feel extremely tired and he lost all sexual desire. The drug temporarily lowered his PSA, but it jumped to 46 when he stopped it.

Mike began researching treatments that would not cause impotence (erectile dysfunction), incontinence (urine leakage) or a host of other side effects. He went on a raw food diet, had his dental amalgams removed and took testosterone blockers, which also eliminated his libido. He joined a clinical trial, but his cancer began to spread and he lost an alarming amount of weight.

While taking part in the clinical trial, Mike met Dr. Antonio Jimenez, Medical Director of the Hope4Cancer Institute in Baja, California. "Dr. Jimenez offered a non-toxic, proven cancer treatment that combined Sono-Photo Dynamic Therapy with radio-wave hyperthermia. Finally, a treatment without side effects!"

As early as age 40, the prostate may begin to increase in size, and by age sixty, 80% of men have an enlarged prostate. This can cause the urethra to narrow, decreasing urine flow. Symptoms include an urgent need to urinate (especially at night), a thin stream, discomfort above the bladder, blood in the urine, low back pain, weak or interrupted flow and pain or burning when urinating. Sometimes, prostate cells begin to grow abnormally, forming a tumor.

Prostate screening normally includes a blood test called PSA, digital rectal exam (DRE) and a Sonogram/Ultrasound. If cancer is suspected, traditional medicine requires a biopsy where a Gleason score (a sy
'/>"/>

SOURCE Hope4Cancer Institute
Copyright©2008 PR Newswire.
All rights reserved

1

GOOD

Page: 1 2 3

Related medicine technology :

1. New Gene Methylation Test for Prostate Cancer Available
2. Medivation Announces Presentation of MDV3100 Clinical Data in Patients With Castration-Resistant Prostate Cancer at 44th American Society of Clinical Oncology Annual Meeting
3. FDA Approves HIFU Clinical Trial for Recurrent Prostate Cancer
4. Preventing Prostate Cancer and BPH: Prostate-Health Expert Available (National Mens Health Week Is June 9-15)
5. Free Prostate Cancer Seminar in Lake Ridge, VA: Dr. Charles Snuffy Myers Announces Vitamin D Clinical Trials
6. Medarex Reports Interim Data from Ongoing Ipilimumab Combination Phase 1 Studies in Prostate Cancer at American Association for Cancer Research Meeting
7. Halozyme Therapeutics Presents Pre-Clinical Studies of Systemic Delivery of Pegylated rHuPH20 Enyzme in Prostate Cancer Models at American Association for Cancer Research Conference
8. Data Presented at AACR Annual Meeting Shows Bavituximab Equivalent Plus Docetaxel Reduces Tumor Growth By Up to 95% and Halts Metastasis in a Model of Hormone-Refractory Prostate Cancer
9. SuperGens MP-470 Sensitizes Prostate and Breast Cancer Cells to Erlotinib
10. Microwave Treatments for Enlarged Prostate Cause Blood Pressure Surges
11. Diagnostic Center for Disease: Prostate Biopsy Spreads Prostate Cancer Cells
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/14/2009)... HEIGHTS, N.J., Dec. 14 Authentidate ... worldwide provider of secure Health Information Exchange ... Home Care of the Carolinas ("HCC"), a ... ("AMI"), a durable medical equipment supplier, have ... streamline and standardize processes for the completion ...
(Date:12/14/2009)... HOPKINTON, Mass., Dec. 14 ... CALP ), a leading provider of tools and ... today announced that it has completed the sale ... provides in-vivo pre-clinical CRO services, to Taconic Farms, ... acquired by Caliper as part of Caliper,s acquisition ...
(Date:12/14/2009)... SAN DIEGO, Dec. 14 ... Merck & Co., Inc., through an affiliate, an exclusive ... Pseudomonas -based recombinant protein expression technology for the production ... the development of an undisclosed vaccine candidate. ,, ... is eligible to receive approximately $52 million in upfront ...
Breaking Medicine Technology:Home Care of the Carolinas and Alliance Medical, Inc. Select Authentidate's Inscrybe Healthcare to Improve Care Order Processing 2Home Care of the Carolinas and Alliance Medical, Inc. Select Authentidate's Inscrybe Healthcare to Improve Care Order Processing 3Home Care of the Carolinas and Alliance Medical, Inc. Select Authentidate's Inscrybe Healthcare to Improve Care Order Processing 4Caliper Completes Strategic Sale of Small Animal Services Subsidiary to Taconic 2Caliper Completes Strategic Sale of Small Animal Services Subsidiary to Taconic 3Caliper Completes Strategic Sale of Small Animal Services Subsidiary to Taconic 4IDRI to Use NanoPass Microneedle Technology for Intradermal Vaccines and Diagnostic Skin Tests 55679 1IDRI to Use NanoPass Microneedle Technology for Intradermal Vaccines and Diagnostic Skin Tests 55679 2BloodStor 28TM 29 Stem Cell Biopreservation Media Platform Launched by BioLife Solutions 13734 1BloodStor 28TM 29 Stem Cell Biopreservation Media Platform Launched by BioLife Solutions 13734 2BloodStor 28TM 29 Stem Cell Biopreservation Media Platform Launched by BioLife Solutions 13734 3Former Veterans Affairs Secretary Joins Integrated Medical Systems Advisory Board 55676 1Former Veterans Affairs Secretary Joins Integrated Medical Systems Advisory Board 55676 2Former Veterans Affairs Secretary Joins Integrated Medical Systems Advisory Board 55676 3
... Development Program in Multiple Myeloma, SOUTH ... Inc.,today announced that patient dosing has commenced ... the safety and efficacy of Proteolix,s lead ... and,dexamethasone in patients with relapsed multiple myeloma. ...
... COPENHAGEN, Denmark, July 9 Summary: Genmab,has completed ... of ofatumumab,in combination with fludarabine and cyclophosphamide to ... announced today it has completed recruitment of,56 patients ... (R)) in,combination with fludarabine and cyclophosphamide (FC) to ...
Other Medicine Technology:Proteolix Initiates Phase 1b Clinical Trial of Carfilzomib in a Combination Regimen for Patients With Relapsed Multiple Myeloma 2Proteolix Initiates Phase 1b Clinical Trial of Carfilzomib in a Combination Regimen for Patients With Relapsed Multiple Myeloma 3Genmab A/S - Company Announcement: Recruitment Completed In Ofatumumab CLL Front Line Study 2Genmab A/S - Company Announcement: Recruitment Completed In Ofatumumab CLL Front Line Study 3
(Date:12/14/2009)... Krause, an aerospace engineer,for NASA, was giving the ... he,was confident that technology and science could solve ... one thing that science couldn,t solve.,His wife Susan ... machines,would keep her alive for awhile, she would ... 69 and is starting dialysis next month. She ...
(Date:12/14/2009)... could be linked to scans performed in 2007 , , ... are exposing patients to far more radiation than previously thought ... cancers a year, two new studies claim. , Based on ... Archives of Internal Medicine , the study authors, joined ... calling on clinicians to limit radiation exposure to patients. , ...
(Date:12/14/2009)... , , MONDAY, Dec. 14 (HealthDay News) -- Here,s good ... a cup or two of java: Coffee and tea ... diabetes. , That,s the conclusion of an Australian ... the lower your risk of diabetes. Every cup of ... the risk of diabetes, the researchers said. , ...
(Date:12/14/2009)... are linked to an increased risk of certain cancers. ... synthetic insulin preparation marketed under the trade name Lantus), ... cancers than other insulins or oral glucose lowering medications. ... important factors such as obesity that may have driven ... large randomized trial designed to examine another aspect of ...
(Date:12/14/2009)... COPD, researchers say , , MONDAY, Dec. 14 (HealthDay News) ... lung function, a finding that may help lead to ... of researchers compared lung function with genetic variants at ... genome in more than 20,000 people of European ancestry. ... variants associated with alterations in lung function. , The ...
Breaking Medicine News(10 mins):Health News:69-Year-Old Grandmother Needing A Lifesaving Kidney Transplant Finds a Miracle on the Internet: a 25-Year-Old Living Altruistic Organ Donor Stranger 2Health News:69-Year-Old Grandmother Needing A Lifesaving Kidney Transplant Finds a Miracle on the Internet: a 25-Year-Old Living Altruistic Organ Donor Stranger 3Health News:Studies Quantify Cancer Risks From CT Scans 2Health News:Studies Quantify Cancer Risks From CT Scans 3Health News:Studies Quantify Cancer Risks From CT Scans 4Health News:Coffee, Tea Might Stave Off Diabetes 2Health News:Coffee, Tea Might Stave Off Diabetes 3Health News:UNC scientists coordinate study of link between insulin use and cancer in people with diabetes 2
... Medicine Cabinet Day Set For Saturday October 13,Proper ... OTC Drug Abuse, CHICAGO, Oct. 8 ... treatment to adolescents, adults and their,families, said today ... an area wide "Clean Out Your Medicine Cabinet" ...
... men who have surgery for prostate cancer appear less likely ... who choose other treatment options, especially if they are younger ... a report in the Oct. 8 issue of Archives of ... treatments are still being debated because they have not yet ...
... Center researcher has been awarded a National Institutes of ... factors, in addition to traditional predictors, can be useful ... disease. , Kevin A. Fiscella, M.D., M.P.H., associate professor ... by the National Heart, Lung and Blood Institute, part ...
... Study finds it outperforming other forms of treatment , ... the best chance of long-term survival for prostate cancer ... University found that prostate cancer patients who had surgery ... 10 years than men who had other types of ...
... of Parkinson,s patients more likely to develop dementia, study ... Relatives of people with Parkinson,s disease face up to ... suggests a new study that says genetics could be ... of the central nervous system, such as impaired motor ...
... WASHINGTON, Oct. 8 Crowell & Moring LLP ... Rhoad to the firm,s,Health Care and False Claims ... represents both health care and government contract clients,in ... Claims Act,(FCA), antitrust claims, and criminal and civil ...
Other Medicine News:Health News:Rosecrance and Chicago's Department of Environment Collaborate to Help Families Dispose of Unwanted Medicines and Drugs 2Health News:Rosecrance and Chicago's Department of Environment Collaborate to Help Families Dispose of Unwanted Medicines and Drugs 3Health News:Swiss study suggests surgery may offer best chance of long-term prostate cancer survival 2Health News:Study to consider social risk in guiding prevention of heart disease 2Health News:Surgery Best Bet for Prostate Cancer Survival 2Health News:Parkinson's Linked to Risk of Alzheimer's 2Health News:Crowell & Moring's Expanding Health Care Litigation Practice Gains Experienced Litigator 2Health News:Crowell & Moring's Expanding Health Care Litigation Practice Gains Experienced Litigator 3
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... ARUP Laboratories is a national reference laboratory ... research and development. ARUP offers an extensive ... medical tests in clinical and anatomic pathology. ... Laboratories' clients include more than half of ...
... a national reference laboratory and a worldwide ... ARUP offers an extensive test menu of ... clinical and anatomic pathology. Owned by the ... more than half of the nation's university ...
... Laboratories is a national reference laboratory and ... and development. ARUP offers an extensive test ... tests in clinical and anatomic pathology. Owned ... clients include more than half of the ...
Medicine Products: